Changes in expression of genes in this pathway, including HSPA5 as a marker of activation of this pathway, are related to a variety of cancers including breast, gastric, lung, colon and prostate cancers characterized by high pathologic levels, tumor recurrence, and low survival [3,7,11]. Here, HSPA5 is linked to cancer.